Literature DB >> 19272303

Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive-compulsive disorder.

Sutirtha Chakraborty1, Om Prakash Singh, Anindya Dasgupta, Nikhiles Mandal, Harendra Nath Das.   

Abstract

Oxidative stress is thought to play an important role in several neuropsychiatric diseases including obsessive-compulsive disorder (OCD). Thiobarbituric acid reacting substances (TBARS) are products formed as a result of free radical induced lipid peroxidation in the human body. Our study investigated the correlation between TBARS and the clinical severity of OCD as indicated by the Yale Brown Obsessive Compulsive Scale (YBOCS). Serum TBARS was estimated in thirty nine newly diagnosed drug free OCD patients and thirty three disease free control subjects. Mean values for serum TBARS were found to be significantly higher (P < 0.001) in cases than in controls (5.85 nmol/ml and 3.90 nmol/ml with an SD of 0.56 and 0.81 respectively). A strong positive correlation (rs = 0.757, p < 0.01) between the lipid peroxidation marker TBARS and the disease severity indicator YBOCS was found among cases. Significant positive correlation was also found between TBARS and the obsessive and compulsive subscales of YBOCS. These findings were in tune with previous studies, which suggested oxidative stress induced increased free radical generation in the OCD patients. Our findings may help in understanding the development and progress of OCD and the treatment of patients of OCD in future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19272303     DOI: 10.1016/j.pnpbp.2009.01.001

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  19 in total

Review 1.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

2.  N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.

Authors:  Jerome Sarris; Georgina Oliver; David A Camfield; Olivia M Dean; Nathan Dowling; Deidre J Smith; Jenifer Murphy; Ranjit Menon; Michael Berk; Scott Blair-West; Chee H Ng
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

3.  Striatal magnetic resonance spectroscopy abnormalities in young adult SAPAP3 knockout mice.

Authors:  Dionyssios Mintzopoulos; Timothy E Gillis; Holly R Robertson; Triana Dalia; Guoping Feng; Scott L Rauch; Marc J Kaufman
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-01-01

Review 4.  N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.

Authors:  Olivia Dean; Frank Giorlando; Michael Berk
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 5.  Peromyscus maniculatus bairdii as a naturalistic mammalian model of obsessive-compulsive disorder: current status and future challenges.

Authors:  De Wet Wolmarans; Isabella M Scheepers; Dan J Stein; Brian H Harvey
Journal:  Metab Brain Dis       Date:  2017-12-06       Impact factor: 3.584

6.  Redox status in workers occupationally exposed to long-term low levels of ionizing radiation: A pilot study.

Authors:  Iman M Ahmad; James B Temme; Maher Y Abdalla; Matthew C Zimmerman
Journal:  Redox Rep       Date:  2016-02-05       Impact factor: 4.412

7.  How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways.

Authors:  Steven Moylan; Felice N Jacka; Julie A Pasco; Michael Berk
Journal:  Brain Behav       Date:  2013-03-26       Impact factor: 2.708

8.  An overview of Indian research in obsessive compulsive disorder.

Authors:  Y C Janardhan Reddy; Naren P Rao; Sumant Khanna
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

9.  N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review.

Authors:  Georgina Oliver; Olivia Dean; David Camfield; Scott Blair-West; Chee Ng; Michael Berk; Jerome Sarris
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

10.  Decreased serum sulphydryl levels as a sign of increased oxidative stress in generalized anxiety disorder.

Authors:  Mehmet Cemal Kaya; Yasin Bez; Ibrahim Fatih Karababa; Ali Emhan; Nurten Aksoy; Mahmut Bulut; Mehmet Guneş; Abdullah Atli; Salih Selek
Journal:  Psychiatry Investig       Date:  2013-09-16       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.